ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of LGX818 and Cetuximab or LGX818, BYL719, and Cetuximab in BRAF Mutant Metastatic Colorectal Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01719380
Recruitment Status : Active, not recruiting
First Posted : November 1, 2012
Last Update Posted : March 21, 2018
Sponsor:
Information provided by (Responsible Party):
Array BioPharma

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : October 31, 2015
  Estimated Study Completion Date : July 31, 2018
  Certification/Extension First Submitted : July 17, 2017